Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Tonix Pharmaceuticals (TNXP) Q2 2026 Earnings
TNXP
11
May
Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-3.86
-3.43
-3
-2.57
Details
Expected EPS
-2.57
Actual EPS
-2.93
Surprise EPS
-0.36
Surprise Percent
+14.01%
Description
Tonix Pharmaceuticals (TNXP) has reported earnings of -2.93 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login